相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical pharmacology of artemisinin-based combination therapies
Francesca T. Aweeka et al.
CLINICAL PHARMACOKINETICS (2008)
Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro
T. H. Min et al.
EXPERIMENTAL PARASITOLOGY (2007)
Venlafaxine induces P-glycoprotein in human Caco-2 cells
M. J. Ehret et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2007)
Transporters involved in resistance to antimalarial drugs
Stephanie G. Valderramos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation
Bjorn Bauer et al.
MOLECULAR PHARMACOLOGY (2006)
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Kenneth N. Agwuh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The efficacy of certain anti-tuberculosis drugs is affected by binding to α-1-acid glycoprotein
Deborah-Ann Johnson et al.
BIOMEDICAL CHROMATOGRAPHY (2006)
Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey
G Senol et al.
JOURNAL OF CHEMOTHERAPY (2005)
Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: Hepatic enzyme-transporter interplay
YY Lau et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
In vitro metabolism of clindamycin in human liver and intestinal microsomes
MA Wynalda et al.
DRUG METABOLISM AND DISPOSITION (2003)
Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria
PN Newton et al.
CLINICAL INFECTIOUS DISEASES (2003)
An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons
EFA Brandon et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2003)
Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria
S Pukrittayakamee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
P-glycoprotein-mediated intestinal and biliary digoxin transport in humans
S Drescher et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Rifampin and Rifabutin drug interactions - An update
CK Finch et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis
MM Thapar et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8:: A new high affinity and turnover enzyme-specific probe substrate
XQ Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4
CL Cummins et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Pharmacokinetic interactions of antimalarial agents
PT Giao et al.
CLINICAL PHARMACOKINETICS (2001)
Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials
WJ Burman et al.
CLINICAL PHARMACOKINETICS (2001)
In vivo modulation of CYP enzymes by quinidine and rifampin
RA Branch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Effect of rifampin on plasma concentrations of mefloquine in healthy volunteers
W Ridtitid et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes
F Fontaine et al.
LIFE SCIENCES (2000)
分享论文
